Atrium Therapeutics, Inc. (RNA)

NASDAQ: RNA · Real-Time Price · USD

12.77

-0.22 (-1.69%)

At close: Apr 30, 2026, 4:00 PM EDT

12.96

+0.19 (1.49%)

After-hours: Apr 30, 2026, 4:16 PM EDT

Atrium Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-0.06	-0.06	-0.11	-0.14
Debt / FCF Ratio	-	-	-	0.18
Net Debt / Equity Ratio	-0.06	-0.06	-0.11	-0.14
Net Debt / EBITDA Ratio	-0.07	-0.07	-0.52	-1.58
Net Debt / FCF Ratio	-0.09	-0.09	-0.30	0.18
Asset Turnover	2.40	2.40	1.25	-
Quick Ratio	0.00	0.00	-	0.02
Current Ratio	0.07	0.07	0.02	0.03
Return on Assets (ROA)	-399.25%	-399.25%	-94.53%	-
Return on Capital Employed (ROCE)	148.40%	148.40%	67.40%	27.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.